Ras g12d inhibitors
TW202635700APending Publication Date: 2026-09-01ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101802
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-17
- Filing Date
- 2026-01-16
- Publication Date
- 2026-09-01
Abstract
The present application relates to compounds and pharmaceutically acceptable salts thereof that inhibit the growth of cancers that express G12D mutant Ras proteins. The molecules of the specification are thus indicated for use in the treatment of cancer that express G12D mutant Ras protein.
Need to check novelty before this filing date? Find Prior Art